While cranial radiation therapy (CRT) remains a major risk factor — with high doses of radiation showing a hazard ratio of ...

Certain chemotherapies are associated with an increased long-term risk of subsequent tumors in survivors of childhood cancer, ...

Children who received cranial radiotherapy to treat their cancer faced an increased risk of developing meningioma — the most common type of benign brain tumor — decades after being exposed, according ...

Primary brain and central nervous system cancers are relatively rare and represent approximately 2% of all cancers diagnosed in the United Kingdom. However, due to a poor prognosis, they are ...

One hundred ninety-nine meningiomas were identified among 169 participants. The median interval from primary cancer to meningioma diagnosis was 22 years (5 to 37 years). The cumulative incidence of a ...

Meningiomas are typically benign tumours, arising from the meninges of the brain (in at least 90% of the cases) and the spinal cord (Berger and Prados, 2004). They are benign in more than 90% of the ...

Neuroscientists have uncovered the genetic basis for why many long-term survivors of childhood cancer develop meningiomas, the most common adult brain tumor, decades after their treatment with cranial ...

NeOnc’s second concurrent Phase 2 clinical study seeks further safety and preliminary evidence of biological effects of its lead drug candidate, NEO100™, on certain cancers of the brain and central ...

Studies show Depo-Provera users have much higher relative risk of developing meningiomas, although overall risk remains low ...

In a cohort study, childhood cancer survivors had an elevated lifetime risk for meningioma (35-year cumulative incidence, 2.3%). High-dose cranial radiation therapy, younger age at diagnosis, female ...